p53, Bax and Bcl-2 expression, and apoptosis in gestational trophoblast of complete hydatidiform mole

Placenta

Volumn 19, Issue 5-6, 1998, Pages 361-369

  Qiao, S ^a   Nagasaka, T ^b   Harada, T ^b   Nakashima, N ^a,b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTROPHOBLAST; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNCYTIOTROPHOBLAST; TROPHOBLAST;

EID: 0031818382     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4004(98)90075-3     Document Type: Article

References (51)

1. Arends MJ & Wylli AH (1993) Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol, 32, 223-254.
2. Barinaga M (1994) Cell suicide by ice, not fire. Science, 263, 754-756.
3. Bear R (1994) Bcl-2 breathes life into embryogenesis. Am J Pathol, 145, 7-10.
4. Deppert W, Buschhausen-Denker G, Patschinsky & Steinmeyer K (1990) Cell cycle control of p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. II: requirement for cell cycle progression. Oncogene, 5, 1701-1706.
5. Fisher SJ, Cui T, Zhang L, Hartmann L, Grahl K, Zhang J, Tarpey J & Damsky CH (1989) Adhesive and degradative properties of human placental cytotrophoblast cells in vitro. J Cell Biol, 109, 891-902.
6. Gavrieli Y, Sherman Y & Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol, 119, 493-501.
7. Gold R, Schmied M, Giegerich G, Breischopf H, Hartung HP, Toyka KV & Lassmann H (1994) Differentiation between cellular apoptosis and necrosis and nick translation techniques. Lab Invest, 71, 219-225.
8. Gompel A, Sabourin JC, Martin A, Yaneva H, Audouin J, Decroix Y & Poitout P (1994) Bcl-2 expression in normal endometrium during the menstrual cycle. Am J Pathol, 144, 1195-1202.
9. Gu Y, Jow GM, Moulton BC, Lee C, Sensibar JA, Park-Sarge OK, Chen TJ & Gibori G (1994) Apoptosis in decidual tissue repression and reorganization. Endocrinology, 135, 1272-1279.
10. Haake A & Polakowsaka R (1993) Cell death by apotptosis in epidermal biology. J Invest Dermatol, 101, 107-112.
11. Hockenbery DM, Zutter M, Hickery W, Nahm M & Korsmeyer SJ (1990) Bcl-2 is a inner mitochondirl membrane protein that blocks programmed cell death. Nature, 348, 334-336.
12. Hockenbery DM, Zutter M, Hickey W, Nahm M & Korsmeyer SJ (1991) bcl-2 protein is topographically restricted to tissue characterized by apoptotic cell death. Proc Natl Acad Sci USA, 88, 6961-6965.
13. Hockenbery DM (1994) bcl-2 in cancer, development and apoptosis. J Cell Science, 18 (Suppl.), 51-55.
14. Hoekstra A & Herscheid JD (1985) The placenta as a substitute for cancerous models. Med Hypotheses, 17, 299-304.
15. Hsu SM, Raine L & Fanger H (1981) Use of avidin-biotin-peroxides complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem, 29, 241-245.
16. Iggo R, Gatter KC, Barter J, Lane D & Harris A (1990) Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet, 335, 675-679.
17. Isobe M, Emanuel B, Givol D, Oren M & Croce CM (1986) Localization of gene for human p53 tumour antigen to band 17p13. Nature, 320, 84-85.
18. Kerr JF, Winterford CM & Harmon BV (1994) Apoptosis. Its significance in cancer and cancer therapy. Cancer, 73, 2013-2026.
19. Kim CJ, Choe YL, Yoon BH, Kim CW & Chi JG (1995) Patterns of bcl-2 expression in placenta. Path Res Prac, 191, 1239-1244.
20. Korsmeyer SJ (1992) Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood, 80, 879-886.
21. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG & Reed JC (1994) Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bel-2. Am J Pathol, 145, 1323-1336.
22. Kurman RJ (1994) Gestational trophoblastic disease and related lesions. In Blaustien's Pathology of the Female Genital Tract, 4th edn. (Ed.) Mazur MT & Kurman RJ, p. 1055. New York: Springer-Verlag.
23. Lane DP & Crawford LV (1979) T antigen is bound to a host protein in SV40-transformed cells. Nature, 278, 261-263.
24. Lane DP (1990) Mutation of the p53 protein: common steps found in the majority of human cancers. In Accomplishments in Cancer Research (Ed.) Fortner JG & Rhodes JE, pp. 256-266. Philadelphia: JP Lippincott.
25. Lane DP (1992) p53, guardian of the genome. Nature, 358, 15-16.
26. Lee YS (1995) P53 expression in gestational trophoblastic disease. Int J Gynecol Pathol, 14, 119-124.
27. Librach CL, Werb Z Fitzgerald ML, Chin K, Conwin NM, Esteres RA, Grobelny D, Damsky CH & Fisher SJ (1991) 92-KD type IV collagenase mediates invasion of human cytotrophoblast. J Cell Biol, 113, 437-449.
28. Lu Q, Poulson R, Wong I & Hanby AM (1993) Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol, 169, 431-437.
29. Lurain JR, Brewer JI, Torok EE & Halpern B (1983) Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol, 145, 591-559.
30. Majno G & Joris I (1995) Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol, 146, 3-15.
31. McConkey DJ, Orrenius S & Jondal M (1990) Cellular signalling in programmed cell death (apoptosis). Immunol Today, 11, 120-121.
32. Miyashita T & Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-299.
33. Miyashita T, Krajewska S, Krajewska M, Wang, HG, Lin HK, Liebermann DA, Huffman B & Reed JC (1994) Tumor suppressor p53 is a regulator of bcl2 and bax gene expression in vitro and in vivo. Oncogene, 9, 1799-805.
34. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC & Vogelstein B (1989) Growth factors, protooncogenes and human placental development. Cell Differ Dev, 342, 705-708.
35. Ohlsson R (1989) Growth factors, protooncogenes and human placental development. Cell Differ Dev, 28, 1-15.
36. Oltvai ZN, Millman CL & Korsmeyer SL (1983) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax that accelerates programmed cell death. Cell, 74, 609-619.
37. Purdie AC, O'Grady J, Piris J, Wyllie AH & Bird CC (1991) p53 expression in colorectal tumours. Am J Pathol, 138, 807-813.
38. Reed JC (1994) Bcl-2 and the regulation of programmed cell death. J Cell Bio, 124, 1-6.
39. Rogel A, Popliker M, Webb C & Oren M (1985) P53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos and tumours. Mol Cell Biol, 5, 2851-2855.
40. Roncalli M, Bulfamante G, Viale G, Springall DR, Alfano R, Comi A, Maggioni M, Polak JM & Coggi G (1994) C-myc and tumour suppressor gene product expression in developing and term human trophoblast. Placenta, 15, 399-409.
41. Schmid K, Ebner R, Jahreis K, Lengeler JW & Titgemeyer F (1991) A sugar-specific porin, ScrY, is involved in sucrose uptake in enteric bacteria. Mol Microbiol, 5, 941-950.
42. Selvakumaran M, Lin HK, Miyashita T, Wang HG, Krajewski S, Reed JC, Hoffman B & Liebermann D (1994) Immediate-early up-regulation of Bax expression by p53 but not TGF β a paradigm for distinct apoptotic pathways. Oncogene, 9, 1791-1798.
43. Silverberg SG, Kurman RJ. (1991) Tumors of the Uterine Corpus and Gestational Trophoblastic Disease. Washington, D.C.: Armed Forces Institute of Pathology.
44. cdc2 in mammalian cells: implications for cell-cycle control and oncogenesis, Oncogene, 5, 795-801.
45. Szulman AE & Suiti U (1984) Complete and partial hydatidiform moles: cytogenetic and morphological aspects. Adv Exp Med Biol, 176, 135-146.
46. Tilly JL, Tiley KI, Kenton ML & Jonson AL (1995) Expression of members of the bel-2 gene family in the immature rat ovary: equine chorionic gonadotropin medicated inhibition of granulosa cell apoptosis is associated with decrease bax and contitutive bcl-2 and bcl-xlong messenger ribonucleic acid levels. Endocrinology, 136, 232-241.
47. Vaux DL, Cory S & Adams JM (1988) Bcl-2 promotes the survival of hematopoietic cells and cooperates with c-myc to immortalize pre-B cells. Nature, 335, 440-442.
48. Wyllie AH, Kerr JF & Currie AR (1980) Cell death: the significance of apoptosis. Int Rev Cytol, 68, 251-306.
49. Yasuda M, Umemura S, Osamura Y, Kenjo T & Tsutsumi Y (1995) Apoptotic cells in the human endometrium and placental villi: Pitfall in applying the TUNEL method. Arch Histol Cytol, 58, 185-190.
50. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A & Oren M (1991) Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature, 352, 345-7.
51. Yui JS, Garcia-Lloret MI, Brown A, Berdan RC, Morrish DW, Wegmann TG & Guilbert LJ (1994) Functional long term cultures of human term trophoblasts purified by column-elimination of CD9 expressing cells. Placenta, 15, 231-246.